Position in ZTS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$238,741,833
-$222,244,056 QoQ
Shares Held
3,322,319
-14.8% QoQ
Ownership
0.804%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#24
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,741,833 | 3,322,319 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $460,985,889 | 3,899,720 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $541,710,574 | 4,305,441 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $544,444,124 | 3,720,914 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $766,872,883 | 4,917,428 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $873,330,923 | 5,304,166 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $906,201,985 | 5,561,910 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,002,002,608 | 5,128,481 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $812,694,681 | 4,687,902 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $763,069,236 | 4,509,599 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $860,120,687 | 4,357,910 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $695,744,097 | 3,998,989 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $662,676,296 | 3,848,071 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $621,917,698 | 3,736,588 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $562,635,925 | 3,839,208 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $569,680,197 | 3,841,663 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $678,820,243 | 3,949,155 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $703,116,694 | 3,728,282 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $1,060,241,527 | 4,344,718 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $818,209,235 | 4,214,532 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $742,103,592 | 3,982,097 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $636,313,682 | 4,040,600 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $726,672,764 | 4,390,772 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $712,994,569 | 4,311,511 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $577,635,378 | 4,215,086 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $498,941,217 | 4,239,453 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||